Seating is Limited
RSVP by April 1th, 2014
Call 518-442-5373 or email
University at Albany donors provide vital support to students and faculty in their scholarly endeavors, and enrich the educational and research initiatives for which UAlbany is so well known.
To support the Hogarty Family Foundation Lectureship Fund visit www.albany.edu/giving.
Thank you for your support!
Hogarty Family Foundation Lecture
Established through the generosity of Daniel J. Hogarty and the Hogarty Family Foundation, an endowed fund provides support for a public lecture program through the University at Albany's Cancer Research Center. The Hogarty Family Foundation Lectures provide information to the community about a broad range of topics related to cancer, cancer genomics and cancer research.
The fifth annual lecture will feature:
Rosemary Rochford, Ph.D.
- Vice President for Research, SUNY Upstate Medical University
- Research Foundation Operations Manager
- Professor of Microbiology and Immunology
Tuesday, April 8th, 2014
- 5:15 p.m. Pre-reception in the Cancer Research Center Atrium
- 6 p.m. Lecture begins in the Massry Conference Center.
Cancer Research Center
University at Albany
1 University Place
Rensselaer, NY 12144
Support provided in part by
About the Speaker
Dr. Rochford received her doctorate and early postdoctoral fellowship training at the University of California at Irvine. She did a second postdoctoral fellowship at The Scripps Research Institute in La Jolla California, and was a staff scientist at Scripps and faculty at the University of Michigan before coming to Upstate in 2003. She became Chair of the Department of Microbiology and Immunology in 2007 and Vice President for Research in 2013.
She has been awarded over $4 million dollars in NIH funding in the last decade to support her research on Burkitt’s lymphoma. She is the author of over 60 peer-reviewed publications, not counting her book chapters and invited reviews. She has served on NIH and DOD study sections.
Her research is focused on understanding how heterologous infections impact development of immunity and disease and specifically how malaria modulates Epstein-Barr virus (EBV) infection. Dr. Rochford utilizes molecular epidemiologic studies based in Kenya as well as a mouse model to uncover the cellular pathways connecting EBV and malaria. These two pathogens are linked to the etiology of endemic Burkitt’s lymphoma, the most common childhood cancer in Equatorial Africa. Her experience working in Kenya has highlighted the need to develop therapies that are suitable for cancer treatment in resource poor areas of the world.
Dr. Rochford is also involved with development of a model to test hemolytic toxicity of anti-malaria drugs using humanized SCID mice. This work is funded through the Department of Defense and Medicine for Malaria Venture and is part of a large collaborative effort between Upstate, the Center for Natural Products in Mississippi and Walter Reed Army Institute of Research.